FRM
ORTX

Fox Run Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Fox Run Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,025
Closed -$45K – 656
2021
Q2 		$45K Buy
+1,025
New +$57.1K 0.04% 331

Other funds holding ORTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fox Run Management's ORTX Position: Q3 2021 in Review

Fox Run Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 1,025 shares — an estimated $45K sold.

Fox Run Management first reported a position in ORTX in Q2 2021 and held it in 1 quarter. The position peaked at $45K in Q2 2021. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

  • Fox Run Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Fox Run Management sold 1,025 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $45K.
  • Fox Run Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2021 and held it in 1 quarter.
  • Fox Run Management's Orchard Therapeutics plc American Depositary Shares position peaked at $45K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Fox Run Management's 13F filing for Q3 2021, filed 15 Nov 2021.